Yiwei Ai
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Extracellular vesicles in disease 2
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Advanced biosensing and bioanalysis techniques 1
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Co-authors
- Xiling Shen (3 shared papers)Pengcheng Bu (3 shared papers)Lihua Wang (2 shared papers)Qianhui Wu (1 shared paper)Michael R. King (1 shared paper)Jiahe Li (1 shared paper)Sweta Roy (1 shared paper)Huanhuan Joyce Chen (2 shared papers)
- Journals
- Science Advances (2 papers)Journal of Biological Chemistry (2 papers)Biomaterials (1 paper)Cell stem cell (1 paper)Heliyon (1 paper)
- Partner nations
- United StatesSingapore
In The Last Decade
Yiwei Ai
9 papers receiving 644 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 232
- Biomaterials 114
- Molecular Biology 451
- Oncology 151
- Biomedical Engineering 169
Countries citing papers authored by Yiwei Ai
This map shows the geographic impact of Yiwei Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Ai more than expected).
Fields of papers citing papers by Yiwei Ai
This network shows the impact of papers produced by Yiwei Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Ai. The network helps show where Yiwei Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiwei Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 266 | |
| 2 | 2016 | 126 | |
| 3 | 2016 | 109 | |
| 4 | 2022 | 77 | |
| 5 | 2024 | 27 | |
| 6 | 2018 | 12 | |
| 7 | 2019 | 12 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 4 |
About Yiwei Ai
Yiwei Ai is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Oncology and Ecology, having authored 9 papers that have together received 644 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer-related molecular mechanisms research (3 papers), Extracellular vesicles in disease (2 papers), RNA modifications and cancer (2 papers), Cancer Cells and Metastasis (2 papers), RNA Research and Splicing (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Cancer Research (232 citations), Biomaterials (114 citations), Molecular Biology (451 citations), Oncology (151 citations) and Biomedical Engineering (169 citations). Yiwei Ai has collaborated with scholars based in United States and Singapore. Frequent co-authors include Xiling Shen, Pengcheng Bu, Lihua Wang, Qianhui Wu, Michael R. King, Jiahe Li, Sweta Roy, Huanhuan Joyce Chen, Steven M. Lipkin and Tara Srinivasan. Their work appears in journals such as Science Advances, Journal of Biological Chemistry, Biomaterials, Cell stem cell and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.